Insider Transactions in Q2 2024 at Vyne Therapeutics Inc. (VYNE)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 31
2024
|
David Domzalski PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,429
+0.88%
|
$8,858
$2.16 P/Share
|
|
Apr 01
2024
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
157
-0.12%
|
$471
$3.08 P/Share
|
|
Apr 01
2024
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-0.07%
|
$282
$3.08 P/Share
|
|
Apr 01
2024
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,004
-0.2%
|
$3,012
$3.08 P/Share
|
|
Apr 01
2024
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
161
-0.11%
|
$483
$3.08 P/Share
|